Pregnancy Test Clause Samples
The Pregnancy Test clause establishes requirements for conducting pregnancy tests, typically in contexts such as clinical trials or employment where pregnancy status may impact eligibility or safety. It usually specifies when and how tests should be administered, who is responsible for the costs, and the actions to be taken based on the results. This clause ensures that all parties are aware of and comply with necessary health and safety protocols, thereby managing risk and maintaining compliance with legal or ethical standards.
Pregnancy Test. BBMR Designated Medical Practitioners will notify the contractor of all female donors who have child bearing potential. Child bearing potential will be assessed at the time of final donor medical assessment.
4.1 A pregnancy test must be performed on all notified donors. Refer to G-CSF Home Administration Letter (LET45). The pregnancy test must be confirmed as Negative before the administration of the first injection of G-CSF.
4.2 The attending nurse must record the test result on the Symptom Monitoring of PBSC Donor during the administration of G-CSF Form (FRM674).
4.3 The contractor will supply a CE marked pregnancy test kit to detect the hormone HCG in the urine.
4.4 The attending nurse should counsel the donor in the event of a Negative test, to ensure that adequate contraception is maintained.
4.5 In the event of a Positive test the attending nurse must immediately contact the BBMR Designated Medical Practitioner and the BBMR Medical Director for advice on further action.
4.6 The attending nurse will counsel the donor in the event of a Positive test.
Pregnancy Test. (women of childbearing potential only)
4.2. Evaluations Conducted Throughout the Study
4.2.1. Retinal Fundoscopy
Pregnancy Test. If you are a female of child bearing age, you will have a urine pregnancy test done to confirm that you are not pregnant. You cannot participate if you are pregnant or plan to become pregnant during the course of the trial.
Pregnancy Test. If you are a woman of child-bearing potential, a urine or blood pregnancy test may be performed. You will be asked to walk back and forth between a start and end point as many times as possible within 6 minutes. You may stop and rest if needed. Right before and right after the test you will be asked questions about how breathless you feel you are.
Pregnancy Test. WOCBP (see Section 9.8) will complete a pregnancy test as indicated in Table 4, or at any time if pregnancy is suspected. Negative test results are required on Day 1 before study drug administration. Any patient who becomes pregnant during the study must discontinue taking study drug immediately. See Section 9.8.3 for a description of procedures to be followed in case of pregnancy.
Pregnancy Test. A serum or urine pregnancy test will be obtained from female subjects who are of childbearing potential as noted in the Schedule of Events.
Pregnancy Test. Insulin. Bandages. Crutches. Acupuncture. Chiropractors. Psychological treatment Smoking cessation programs. You can't use your FSA to pay the entries in the gym, counter-free medicines without prescription, vitamins or cosmetic procedures. In some cases, such as smoking cessation or diet advice, you may need a Doctor's Referral to show that you really need coverage. For a complete list of covered treatments and rules, check the IRS document on approved medical expenses. Determines your annual contribution during open enrollment, you decide how much you think you can allocate your FSA. You can contribute up to $ 2.550 in 2016, but you can adjust the quantity only during open recording. If your first job, you will need to do some forecasts. Read carefully the health care plan offered by the employer for The cost of copays. If you have underlying conditions, such as asthma or diabetes, factor as you pay for your medications. So it also considers other needs. For example, you can use funds for dental care or visions (including copying). I fsa are à ¢ â,¬ å "use-o-lose, à ¢ â,¬ means the amount in your account account They expire at the end of the year. However, employers have two options to prevent employees to lose any remaining funds at the end of the year: bring the funds or apply a period of grace. The first option allows you to carry over $ 500 to the following year. The second option offers a period of grace for 2.5 months to spend the remaining funds. Employers can offer or option, but not both. The bottom line There is no size-size-fit, all when it comes to flexible savings accounts. To decide if one is right for you, predictable health and related related expenses for the year and acquire familiarity with the FSA plan offered. à ¢ â,¬ "You have to read the plan of your company to know what you are entering because it could be more restrictive than the IRS is", says ▇▇▇▇▇▇ trousers, personal finance expert and professor of finance at the Northeastern University Dà ¢ â,¬  "¢ Love-▇▇▇▇▇ School of Business in Boston. à ¢ â,¬ "give time to understand it and seek help if you need it.â € ▇▇▇▇ ▇▇▇▇▇▇▇▇ is a staff writer who covers personal finance for Nerdwallet. Follow it on Twitter @annahelhoski. This article updated the 20th May 2016. Originally published May 27, 2015. You will often find the best ratings displayed on the company's insurer's web page, and you may see these assessments mentioned in car and home reviews. But what actually mean the best ins...
Pregnancy Test. A serum or urine pregnancy test will be performed at Screening for all females of childbearing potential. A pregnancy test also should be performed before the first dose of tazemetostat if the Screening pregnancy test was >72 hrs prior. (Urine or serum test is acceptable however, positive urine tests must be confirmed with serum testing.)
Pregnancy Test. Urine will be collected from females who are of childbearing potential for a pregnancy test and tested in clinic according to site standard procedures.
Pregnancy Test. A urine sample will be collected for a human chorionic gonadotropin pregnancy test as per the schedule in Table 4 and Table 5, for all female subjects of childbearing potential. If this is found to be positive, it will be followed-up with a serum pregnancy test (β-human chorionic gonadotropin). Any subject becoming pregnant during the study will be withdrawn. All pregnancies that occur during the study are to be reported as described in Section 8.1.5.